A Multi-Center, Randomized, Double-Blind, Placebo-Contro

Project: Research project

Description

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety
StatusActive
Effective start/end date12/18/0712/31/20

Funding

  • Alnylam Pharmaceuticals, Inc.

Fingerprint

Placebos
Safety